Genomic Prediction

Genomic Prediction provides advanced genomic tests which improve IVF health outcomes. Genomic Prediction Inc. (GP) was incorporated in Delaware, May 1, 2017. The research insights which led to the creation of GP stretch back much further. Research and data exchange agreements to develop molecular methodology, signed with some of the largest biotechnology vendors in the world, were ongoing as early as 2015. In the decade prior, the founders work in embryology, detection of chromosomal abnormality, computational genomics, algorithms, and polygenic architecture led to GPs superior and innovative methodology for the genetic testing of human embryos. GPs products incorporate fundamental improvements...

Pgs,pgd,pgt,preimplantation genetic testing,polygenic disease risk,ivf,ivd,machine learning,and genomic prediction

Genomic prediction operates in the Biotechnology research industry.

Genomic prediction's revenue is 11m - 100m

Genomic prediction has 11 - 50 employees.